Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Pallas Health vs Rex MD

Two GLP-1 desks, one scoreboard. We put Pallas Health and Rex MD head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 217 · Grade C

Pallas Health

Visit Pallas Health Full brief →
vs
Higher Brief ScoreNo. 135 · Grade C

Rex MD

Visit Rex MD Full brief →

The verdict

Rex MD takes this head-to-head.

Rex MD scores 71 to 63 on our six-factor Brief Score — Rex MD is a US-based men's-health telehealth platform (a LifeMD brand) offering a 100 percent online GLP-1 weight-management program.

That doesn't make Pallas Health a bad call — it's best for readers who can absorb $597 in a single charge every 12 weeks and want a desk that will tell them who compounds and who prescribes — not readers budgeting a predictable monthly bill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
50
58
Supply Reliability
82
77
Transparency
58
48
Access Breadth
66
96
Clinical Oversight
78
84
Track Record
44
78
Pallas HealthBrief Score 63 · 71Rex MD

Price, coverage & the tracker

Pallas HealthRex MD
Brief Score63/100 (C)71/100 (C)
Semaglutide$199/mo average, compounded — but it bills $597 every 12 weeks, not monthly ($139 first 4 weeks)From $199/mo (brand-name)
Tirzepatide$299/mo average, compounded — but it bills $897 every 12 weeks, not monthly ($179 first 4 weeks)From $349/mo (brand Zepbound)
CoverageNationwide — all 50 states + DCAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
On the trackerNewnew to the tracker, no prior readingNewnew to the tracker, no prior reading

Pallas Health: First reading, 7 August 2026. The advertised averages are $199/mo semaglutide and $299/mo tirzepatide, but no month-to-month plan exists to buy: the charge is $139 up front, then $597 every 12 weeks from four weeks after approval ($179, then $897, on tirzepatide). Because an 84-day cycle recurs 4.35 times a year rather than four, those renewal terms work out at roughly $216 and $325 a month once the intro period is behind you.

Rex MD: New to the tracker on 1 August 2026. The published line reads From $199/mo (brand-name) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.